Ropinirole approved for Parkinson's disease.
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D000978:Antiparkinson Agents; D007211:Indoles; C046649:ropinirole